Our medical team’s research expertise, dedication and profound knowledge on aging factors were conducive to a revolutionary discovery by developing a proprietary biotechnological procedure. They extracted the cellular plasma of this unique orchid in such a way that all active compounds could remain intact, and its protective and healing properties for the skin can be retained in a bio-sensitive formulation. These years of research and development resulted in the world’s first Plasmaceuticals™, REDEEM®.

Plasmaceuticals™ are defined today as a topically applied functional gel-like substance that contains intact bio-active constituents of the cellular plasma of bio-active plants and algae. 

Rigorous scientific and clinical testing by highly regarded academic and research institutions confirm REDEEM®’s extraordinary effects on the skin and remarkable effectiveness to respond to the multifactorial causes of skin aging.

REDEEM®’s new approach marks a milestone in skin care science globally to treat skin aging by preventing, sustaining, repairing and restoring photo-aged skin.